Table 7.
Baseline characteristics of the study participants (n = 116)
| All patients (n = 116) | |
|---|---|
| Age (years) | 58.4 ± 14.4 |
| Males (%) | 61 |
| Duration of hemodialysis (months) | 123 (60 to 190) |
| Cause of CKD (%) | |
| GN | 73 |
| diabetes | 12 |
| cystic kidney disease | 3 |
| hypertension | 3 |
| others | 9 |
| Corrected calcium (mg/dl) | 9.35 ± 0.72 |
| Phosphorus (mg/dl) | 7.31 ± 0.90 |
| 6 to <7 mg/dl (%) | 38 |
| ≥7 mg/dl (%) | 62 |
| Intact PTH (pg/ml) | 217 (142 to 323) |
| Medication (%) | |
| sevelamer hydrochloride | 62 |
| calcium carbonate | 66 |
| calcium lactate | 3 |
| oral vitamin D sterols | |
| calcitriol | 9 |
| alfacalcidol | 22 |
| falecalcitriol | 2 |
| intravenous vitamin D sterols | |
| calcitriol | 5 |
| maxacalcitol | 44 |
| cinacalcet hydrochloride | 29 |
Continuous variables are presented as mean ±SD or median (interquartile range), as appropriate. Categorical variables are presented as a percentage.